A new review published in the Journal of Experimental & Clinical Cancer Research describes how mounting evidence confirms that vitamin C has the potential to be a potent anti-cancer agent when administered intravenously in high doses. Authored by researchers from the Department of Medical Oncology at the University Medical Center in Amsterdam, the Netherlands, the paper notes that clinical trials have confirmed the safety and indicated the efficacy of intravenous vitamin C (IVC) in eradicating tumor cells of various types. Stating that the implementation of high-dose vitamin C may be a breakthrough in the treatment of cancer patients with poor prognosis and few available treatment options, the researchers conclude that further clinical examination of this promising and non-toxic treatment modality is not only warranted, but also highly needed.